Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/ONC

ONC

BeOne Medicines AG

Healthcare - US

BeOne Medicines Ltd. (ONC) is a global oncology company that discovers, develops and commercializes innovative cancer treatments spanning hematology and solid tumors; its marketed products include BRUKINSA (zanubrutinib), a second-generatio…

HQ: Basel, PA, Switzerlandbeonemedicines.com

USD346.51+1.38%vs prev. close

Market snapshot

Price

USD346.51

Daily move

+1.38%

P/E

61.0

EPS TTM

5.68

Dividend yield

—

Beta

0.52

Market cap

36.1B

Price history

ONC price

USD

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
BeOne Medicines	ONC	Biotechnology	36.1	61.0	—	-3.3%	-3.5%	+31.0%	+22.0%	+3.2%	+14.1%

Subscribe to Equity Analytics to compare ONC with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.